Market Tracker

11/21 12:44pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

5.99
Real-Time Quote
 +0.23 / +3.99%
Today’s Change
3.11
Today|||52-Week Range
7.82
+6.39%
Year-to-Date

Today’s Trading

Previous close5.76
Today’s open5.93
Day’s range5.77 - 6.04
Volume2,788,885
Average volume (3 months)4,615,063
Market cap$709.4M
Dividend yield--
Data as of 12:29pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+86.25%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book14.44

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.29-1.41%
MGNXMacroGenics Inc+1.22+4.67%
INFIInfinity Pharmaceuti...+0.07+0.49%
TTPHTetraphase Pharmaceu...-0.08-0.36%
Data as of 12:44pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts